Michael Klichinsky

Company: Carisma Therapeutics

Job title: Co-Founder & Chief Scientific Officer

Seminars:

Industry leader’s Fireside Chat: Navigating the Path to the Clinic to Accelerate Clinical Efficacy 8:40 am

Discussing preclinical development best practices to supercharge preclinical approval Discussing translational and IND approval challenges Highlighting clinical successesRead more

day: Day One

Translating & Harnessing Key Learnings from Ex Vivo Therapies to Supercharge In Vivo Clinical Progression 4:00 pm

Reviewing the translational capacity of current preclinical models to highlight required improvements in model type and size Identifying suitable animal models based on specific therapeutic indications and desired outcomes to produce reliable, translational results and accelerate clinical progression Showcasing the evolution from ex vivo to in vivo CAR TherapiesRead more

day: Day One